Bruce Stouch

Dr. Stouch has worked both domestically (FDA and CMS), and internationally (Canadian Ministry of Health, IQWiG, PMDA in Japan, and the EMEA) as an expert statistical resource for clients in preparing clinical trial designs and analyses in support of product labeling claims. Dr. Stouch has over 25 years of biostatistical analysis experience in pharmaceuticals, medical devices, and in vitro diagnostics. For twelve years, Dr. Stouch held the position of Director of Biostatistics and Scientific Data Management at Johnson & Johnson, where he was responsible for strategic development and implementation of pharmacoeconomic models for existing and emerging technologies in several therapeutic areas. Over the past decade, Dr. Stouch has served as a consultant to several leading pharmaceutical companies (Sanofi-Synthelabo, Abbott Laboratories, etc.) in designing adaptive clinical trials and prospective monitoring strategies based on conditional and predictive power. Dr. Stouch has been involved in over 50 publications and acknowledgements. Dr. Stouch received his Ph.D. in Biostatistics and Epidemiology through a cooperative program sponsored by Johnson & Johnson, with post-graduate studies at Temple University, Jefferson Medical College, and Harvard School of Public Health. Dr. Stouch also holds advanced degrees in mathematics and computer science.